These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 26950278)
1. Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts. Cao L; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Yu JT; Tan L; Oncotarget; 2016 Mar; 7(12):13319-27. PubMed ID: 26950278 [TBL] [Abstract][Full Text] [Related]
2. HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study. Leduc V; De Beaumont L; Théroux L; Dea D; Aisen P; Petersen RC; ; Dufour R; Poirier J Mol Psychiatry; 2015 Jul; 20(7):867-73. PubMed ID: 25023145 [TBL] [Abstract][Full Text] [Related]
3. Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts. Zhu XC; Wang HF; Jiang T; Lu H; Tan MS; Tan CC; Tan L; Tan L; Yu JT; Mol Neurobiol; 2017 Jan; 54(1):551-562. PubMed ID: 26742530 [TBL] [Abstract][Full Text] [Related]
4. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study. Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S; J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728 [TBL] [Abstract][Full Text] [Related]
5. Multiple genetic imaging study of the association between cholesterol metabolism and brain functional alterations in individuals with risk factors for Alzheimer's disease. Bai F; Yuan Y; Shi Y; Zhang Z Oncotarget; 2016 Mar; 7(13):15315-28. PubMed ID: 26985771 [TBL] [Abstract][Full Text] [Related]
6. Effects of rs3846662 Variants on HMGCR mRNA and Protein Levels and on Markers of Alzheimer's Disease Pathology. Leduc V; Théroux L; Dea D; Dufour R; Poirier J J Mol Neurosci; 2016 Jan; 58(1):109-19. PubMed ID: 26541602 [TBL] [Abstract][Full Text] [Related]
7. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion. Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523 [TBL] [Abstract][Full Text] [Related]
9. Improved Diagnostic Multimodal Biomarkers for Alzheimer's Disease and Mild Cognitive Impairment. Martínez-Torteya A; Treviño V; Tamez-Peña JG Biomed Res Int; 2015; 2015():961314. PubMed ID: 26106620 [TBL] [Abstract][Full Text] [Related]
10. A 'Comprehensive Visual Rating Scale' for predicting progression to dementia in patients with mild cognitive impairment. Jang JW; Park JH; Kim S; Park YH; Pyun JM; Lim JS; Kim Y; Youn YC; Kim S; PLoS One; 2018; 13(8):e0201852. PubMed ID: 30125290 [TBL] [Abstract][Full Text] [Related]
11. Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers. Dukart J; Sambataro F; Bertolino A J Alzheimers Dis; 2016; 49(4):1143-59. PubMed ID: 26599054 [TBL] [Abstract][Full Text] [Related]
12. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease. Löwe LC; Gaser C; Franke K; PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431 [TBL] [Abstract][Full Text] [Related]
13. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters. Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN; Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760 [TBL] [Abstract][Full Text] [Related]
14. Biomarker Extraction Based on Subspace Learning for the Prediction of Mild Cognitive Impairment Conversion. Li Y; Fang Y; Wang J; Zhang H; Hu B Biomed Res Int; 2021; 2021():5531940. PubMed ID: 34513992 [TBL] [Abstract][Full Text] [Related]
15. Apathy as a feature of prodromal Alzheimer's disease: an FDG-PET ADNI study. Delrieu J; Desmidt T; Camus V; Sourdet S; Boutoleau-Bretonnière C; Mullin E; Vellas B; Payoux P; Lebouvier T; Int J Geriatr Psychiatry; 2015 May; 30(5):470-7. PubMed ID: 24953008 [TBL] [Abstract][Full Text] [Related]
16. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers. Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L; J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024 [TBL] [Abstract][Full Text] [Related]
17. Effects of HLA-DRB1/DQB1 Genetic Variants on Neuroimaging in Healthy, Mild Cognitive Impairment, and Alzheimer's Disease Cohorts. Wang ZX; Wang HF; Tan L; Liu J; Wan Y; Sun FR; Tan MS; Tan CC; Jiang T; Tan L; Yu JT; Mol Neurobiol; 2017 Jul; 54(5):3181-3188. PubMed ID: 27056075 [TBL] [Abstract][Full Text] [Related]
18. Impacts of CD33 Genetic Variations on the Atrophy Rates of Hippocampus and Parahippocampal Gyrus in Normal Aging and Mild Cognitive Impairment. Wang WY; Liu Y; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Tan L; Yu JT; Mol Neurobiol; 2017 Mar; 54(2):1111-1118. PubMed ID: 26803496 [TBL] [Abstract][Full Text] [Related]
19. Peripheral versus Central Index of Metabolic Dysfunction and Associations with Clinical and Pathological Outcomes in Alzheimer's Disease. McLimans KE; Webb JL; Anantharam V; Kanthasamy A; Willette AA; J Alzheimers Dis; 2017; 60(4):1313-1324. PubMed ID: 28968233 [TBL] [Abstract][Full Text] [Related]
20. Association study of rs3846662 with Alzheimer's disease in a population-based cohort: the Cache County Study. Wright SM; Jensen SL; Cockriel KL; Davis B; Tschanz JT; Munger RG; Corcoran CD; Kauwe JSK Neurobiol Aging; 2019 Dec; 84():242.e1-242.e6. PubMed ID: 30975575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]